Abstract:OBJECTIVE:To evaluate the effects of intratympanic dexamethasone injection on patients with profound sudden hearing loss.METHODS:All patients in the present study were profound sudden hearing loss, with initial hearing loss of more than 90 dB, but no previous interventions was conducted on the 78 patients within 2 weeks onset of sudden hearing loss. Patients were assigned to 3 groups according to patients' choice, Group I (local and general dexamethasone administration, 22 cases), Group II (Intravenous dexamethasone injection, 44 cases), Group III (intratympanic dexamethasone injection, 12 cases). In addition, vessel dilation drugs, neurotrophic and hyperbaric oxygen therapy were also conducted on all patients. Intravenous dexamethasone was applied 15 mg/dx3 d, 10 mg/dx3 d and 5 mg/dx3 d, respectively. Intratympanic dexamethasone (5 mg/ml, 0.8 ml) injection was performed during 10 days (1 injection/2 days). Pure tone test was conducted on 10th, 20th, and 30th day after intervention.RESULTS:The factors which may impact on the prognosis were matched in all three groups. The threshold improvement more than 30 dB was 81.82% in group I, 83.3% in group II and 88.64% in group III. Statistical study showed there was no significant different among 3 groups (P=0.726). On the 30th day after intervention, pure tone threshold improvement was 41.36 dB in group I (local and general dexamethasone administration), 43.08 dB in group II (intravenous dexamethasone injection) and 51.70 dB in group III (intratympanic dexamethasone injection). Furthermore, pure tone threshold improvement among the 3 groups was no statistical different (F=1.58, P=0.2133). Obvious hearing improvement was noted on the 10th day after intervention, but no further improvement showed after 20 days intervention. More hearing improvement was revealed in the low frequency, while less hearing improvement was achieved in the high frequency.CONCLUSIONS:Comparison with intravenous dexamethasone injection, intratympanic dexamethasone injection did not provide more hearing improvement on patients with profound sudden hearing loss.

Cochlear blood flow during occlusion and reperfusion of the anterior inferior cerebellar artery--effect of topical application of dexamethasone to the round window

Clinical efficacy of ITD combined with intravenous dexamethasone and traditional method in treatment of sudden deafness

[Structure and Function Influence of Cochlear after Dexamethasone Intratympanic Application].

Response of cochlear blood flow to prostaglandin E1 applied topically to the round window

Effect of topical dexamethasone on sensorineural hearing loss in endotoxin-induced otitis media

Therapeutic Efficacy of Topical Application of Dexamethasone to the Round Window Niche after Acoustic Trauma Caused by Intensive Impulse Noise in Guinea Pigs

A Comparison of Systemic and Local Dexamethasone Administration: from Perilymph/cochlea Concentration to Cochlear Distribution.

Intratympanic Dexamethasone As Initial Therapy for Idiopathic Sudden Sensorineural Hearing Loss: Clinical Evaluation and Laboratory Investigation

Distribution of Dexamethasone in Cochlea after Intratympanic Injection in Rats

Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig

Local inner ear application of dexamethasone in cochlear implant models is safe for auditory neurons and increases the neuroprotective effect of chronic electrical stimulation

Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane

Differences in hearing recovery following intratympanic alone or intravenous dexamethasone with rescue intratympanic steroids for sudden sensorineural hearing loss: A randomised trial

The Pharmacokinetic Profiles of Dexamethasone and Methylprednisolone Concentration in Perilymph and Plasma Following Systemic and Local Administration

Role of mannitol in reducing postischemic changes in distortion-product otoacoustic emissions (DPOAEs): a rabbit model

The effect of propofol infusion with topical epinephrine on cochlear blood flow and hearing: An experimental study

Junctional Modulation of Round Window Membrane Enhances Dexamethasone Uptake into the Inner Ear and Recovery after NIHL

[Preliminary Study on Intratympanic Dexamethasone Injection for Management of Patients with Profound Sudden Hearing Loss].

Therapeutic efficacy of middle ear administration of dexamethasone on impulsive noise-induced hearing loss: an experimental study

Intratympanic steroid delivery by an indwelling catheter in refractory severe sudden sensorineural hearing loss

The effect of topically administered latanoprost on the cochlear blood flow and hearing